JELLY_1170x120_9-8-20

Moderna

Moderna announces COVID-19 vaccine deal

Moderna announces COVID-19 vaccine deal

CAMBRIDGE, Mass.— Moderna announced that the U.S. government has secured 100 million doses of mRNA-1273 as part of the U.S. government’s goal of securing early access to safe and effective COVID-19 vaccines for the American people. The award of up to $1.525 billion is for the manufacturing and delivery of 100 million doses of mRNA-1273

AWS powers Moderna’s digital biotechnology platform

AWS powers Moderna’s digital biotechnology platform

SEATTLE — Amazon Web Services (AWS), an Amazon.com company, announced Wednesday that Moderna  has selected AWS as its preferred cloud provider, as well as its standard for analytics and machine learning workloads. Leveraging its mRNA platform and manufacturing facility with the AWS-powered research engine, Moderna delivered the first clinical batch of its vaccine candidate (mRNA-1273)

Moderna’s COVID-19 vaccine moving to a bigger study

Moderna’s COVID-19 vaccine moving to a bigger study

NEW YORK — According to a story in the Wall Street Journal, details about the first human study of Moderna Inc.’s experimental coronavirus vaccine emerged Tuesday, which researchers said reinforced their decision to take the shot into a large, decisive clinical trial scheduled to start in late July. The new results, published online by the New